New Insights on the Role of PD-1 in Merkel Cell Carcinoma
Programmed cell death 1 (PD-1) inhibitors have been approved for treating various types of cancer, but PD-1 functions can vary between different cell and cancer types, either promoting or suppressing disease progression. Merkel cell carcinoma (MCC) responds well to immune checkpoint inhibitor therapy, but it unknown if MCC cells express PD-1 themselves. In addition, researchers […]